A new warning from the American Food and Drug Administration sparked controversy around the use of albaracetamol (Tylinol) during pregnancy. واشتباه بلتوحد عرض المزيد ومتعددة, خبراء دوليون confirms that the evidence is still different, and they warn against the early conclusions.
Acetaminophen is one of the most common pain relievers during pregnancy, consumed by almost half of pregnant women around the world. It is known as baracetamol in countries such as Europe, Australia, New Zealand, and India. It contains the active substance acetylaminophen, the most common pain reliever during pregnancy.
The American Food and Drug Administration announced today the addition of a new warning sticker on the drug that indicates the possibility of a connection between the drug ក្រង្រ្រ្រ This comes in the wake of the statements of the American President Donald Trump بان تانوال تايلينول “غير موفيد”.
يُوزر مصابعون بالتوحد differences in their social interaction and communication, and the reports indicate an increase in the spread of Altohad in some countries in recent decades, however, many researchers in the field of unity have warned that the data relating to unity بالاسيتامينوفين غير كافيفي, وان حكوم على هذا لعبة يُعدّ تشتيتًا للانتباه.
نفى الحبرة الطبيون حول العلام هذا الادعاعات في الدعائة بل وصفها في العربية العربية على جمعة. The British health authorities have confirmed that Al-Sitamin is still the safest and most commercially available hospital for pregnant women.
دراست حول البراسيتامول والتوحد
There are still scientific evidence related to the possibility of the existence of a connection between al-Barasitamol and tauhad. previous:
In 2008, a study indicated that the use of albaracetamol in children between the ages of 12 and 18 was associated with increased risk. بلتوحد صحاثً. However, the researchers insisted that the results were not significant and required more research.
البراسيتامول والتوحد
In 2019, a study conducted at the Johns Hopkins Bloomberg School of Public Health established a possible relationship between exposure to paracetamol before The birth and the birth, however, this study was also limited because it was difficult to establish the causal links.
And finally, in the year 2024, one of the biggest studies so far was conducted, where the records of 2.5 million siblings were born in Sweden over 25 عامًا. This study concluded that there was no increase in the risk of autism in children whose mothers took albaracetamol during The pregnancy compared to their mothers.
Because this study took into account genetic and environmental factors related to the family, it carries a greater weight than many previous reports.
